Cargando…
PPARδ status and mismatch repair mediated neoplasia in the mouse intestine
BACKGROUND: Therapeutic regulation of PPARδ activity using selective agonists has been proposed for various disorders. However, the consequences of altered peroxisome proliferator-activated receptor delta (PPARδ) activity in the context of intestinal tumourigenesis remain somewhat unclear. Contradic...
Autores principales: | Reed, Karen R, Sansom, Owen J, Hayes, Anthony J, Gescher, Andreas J, Peters, Jeffrey M, Clarke, Alan R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513246/ https://www.ncbi.nlm.nih.gov/pubmed/16672050 http://dx.doi.org/10.1186/1471-2407-6-113 |
Ejemplares similares
-
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008) -
PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
por: Glazer, Robert I.
Publicado: (2016) -
Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
por: Peters, Jeffrey M., et al.
Publicado: (2015) -
A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine
por: Reed, Karen R, et al.
Publicado: (2008) -
Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
por: Peters, Jeffrey M., et al.
Publicado: (2019)